| Literature DB >> 30035749 |
Ian A Myles1, Erik D Anderson1, Noah J Earland1, Kol A Zarember2, Inka Sastalla1, Kelli W Williams1, Portia Gough1, Ian N Moore3, Sundar Ganesan4, Cedar J Fowler1, Arian Laurence5, Mary Garofalo2, Douglas B Kuhns6, Mark D Kieh1, Arhum Saleem1, Pamela A Welch1, Dirk A Darnell1, John I Gallin2, Alexandra F Freeman1, Steven M Holland1, Sandip K Datta1.
Abstract
Autosomal dominant hyper IgE syndrome (AD-HIES), or Job's syndrome, is a primary immune deficiency caused by dominant-negative mutations in STAT3. Recurrent Staphylococcus aureus skin abscesses are a defining feature of this syndrome. A widely held hypothesis that defects in peripheral Th17 differentiation confer this susceptibility has never been directly evaluated. To assess the cutaneous immune response in AD-HIES, we induced suction blisters in healthy volunteers (HVs) and patients with AD-HIES and then challenged the wound with lethally irradiated bacteria. We show that cutaneous production of IL-17A and IL-17F was normal in patients with AD-HIES. Overproduction of TNF-α differentiated the responses in AD-HIES from HVs. This was associated with reduced IL-10 family signaling in blister-infiltrating cells and defective epithelial cell function. Mouse models of AD-HIES recapitulated these aberrant epithelial responses to S. aureus and involved defective epithelial-to-mesenchymal transition (EMT) rather than a failure of bacterial killing. Defective responses in mouse models of AD-HIES and primary keratinocyte cultures from patients with AD-HIES could be reversed by TNF-α blockade and by drugs with reported modulatory effects on EMT. Our results identify these as potential therapeutic approaches in patients with AD-HIES suffering S. aureus infections.Entities:
Keywords: Immunology; Immunotherapy; Infectious disease
Mesh:
Substances:
Year: 2018 PMID: 30035749 PMCID: PMC6063472 DOI: 10.1172/JCI121486
Source DB: PubMed Journal: J Clin Invest ISSN: 0021-9738 Impact factor: 14.808